Baudax Bio, Inc. NASDAQ Updated Mar 8, 2021 10:51 PM BXRX 1.21 0.01 (0.82%). The sector with the best average Zacks Rank would be considered the top sector (1 out of 16), which would place it in the top 1% of Zacks Ranked Sectors. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. Detailed statistics for Baudax Bio (BXRX) stock, including valuation metrics, financial numbers, share information and more. Baudax Bio to Report 2020 Annual Financial Results and Host Conference Call and Webcast on February 16, 2021 • Feb 10, 2021 Baudax Bio Announces $17.6 Million Offering Priced At-the-Market … By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service. Free forex prices, toplists, indices and lots more. Volume today is below average. Subscription Rights . The Malvern pharmaceutical company, spun out of Recro Pharma in 2019, has entered … Get the latest Baudax Bio detailed stock quotes, stock trade data, stock price info, and performance analysis, including Baudax … The 12-month stock price forecast is 4.67, which is an increase of 282.79% from the latest price. Baudax Bio (BXRX) news for Friday surrounding approval from the U.S. Food & Drug Administration has BXRX stock taking off. In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks Rank Education -- Learn more about the Zacks Rank Baudax Bio, Inc. Common Stock (BXRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%. BXRX : 1.2200 (+2.09%) Baudax Bio Reports 2020 Annual Financial Results GlobeNewswire - Tue Feb 16, 6:00AM CST Price Target Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 96% of the market scoring higher. Baudax Bio, Inc. (NASDAQ:BXRX) concluded the trading at $1.2 on Thursday, Mar 04, with a fall of -8.08% from its closing price on previous day. BXRX | Complete Baudax Bio Inc. stock news by MarketWatch. It focuses on the development and commercialization of products for acute care settings. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities. The average Baudax Bio stock price prediction forecasts a potential downside of N/A from the current BXRX share price of $1.43. We currently have multiple therapeutic candidates across early, mid and late-stage clinical development, including a FDA … All quotes are in local exchange time. Zacks Rank Education - Learn about the Zacks Rank, Zacks Rank Home - Zacks Rank resources in one place, Zacks Premium - The only way to fully access the Zacks Rank. Baudax Bio Inc (BXRX) has risen Wednesday morning, with the stock adding 7.43% in pre-market trading to 1.59. GlobeNewswire 16d: Baudax Bio EPS misses … The Zacks Sector Rank assigns a rating to each of the 16 Sectors based on their average Zacks Rank. Is the Options Market Predicting a Spike in Baudax Bio (BXRX) Stock? See the Full List of Stocks To Beat Earnings. Delayed quotes by Sungard. Baudax Bio News: BXRX Stock Soars 15% on FDA Drug Approval The drug will launch in April or May By William White , InvestorPlace Writer Feb 21, 2020, 3:44 pm EST February 21, 2020 Taking a look at stock … BXRX's short-term technical score of 2 indicates that the stock has traded less bullishly over the last month than 98% of stocks on the market. Baudax Bio's share price could stay at $14.00 by May 11, 2021. Baudax Bio, Inc. Common Stock (BXRX) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets. Baudax Bio News: BXRX Stock Soars 15% on FDA Drug Approval By William White, InvestorPlace Writer Feb 21, 2020 Baudax Bio (BXRX) news for Friday surrounding approval from the U.S. Food & … The average Baudax Bio stock price prediction forecasts a potential downside of N/A from the … in the Information. also free. The share float percentage for the stock currently stands at 19.06%. Have Watchlists? Only 13.10% of the stock of Baudax Bio is held by insiders. Since then, BXRX shares have decreased by … The Malvern pharmaceutical company, spun out of … Baudax Bio (NASDAQ:BXRX) Price Target and Consensus Rating 2 Wall Street analysts have issued ratings and price targets for Baudax Bio in the last 12 months. This is an estimated date of earnings release. Intraday data delayed at least 15 minutes or per exchange requirements. The stock’s … The stock's open price was 1.2. As of Dec 30, 2020, the company held 4.99% of the shares, roughly 3.5 … A sector with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's. Post-Market 0.00 (0.00%) Baudax Bio, Inc. (BXRX) registered a 3.31% upside in the last session and has traded in the green over the past 5 sessions. Privacy Notice, and the Web site, including, but not limited to Information originated by Zacks Post-Market 0.00 (0.00%) Get the hottest stocks to trade every day before the market opens 100% free. So far 4,592,061 shares have traded compared to average volume of 6,168,700 shares. This browser is no longer supported at MarketWatch. In the Biotechnology industry which is number 89 by this metric, BXRX ranks better than 9% of stocks. Real time prices by BATS. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style. Neither Zacks Investment This includes personalizing content and advertising. The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank. To screen for more stocks like Baudax Bio Inc click here. The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season. Stock analysis for Baudax Bio Inc (BXRX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Log in to see them here or sign up to get started. There are 50 institutions holding the Baudax Bio, Inc. stock share, with Armistice Capital, LLC the top institutional holder. Historical and current end-of-day data provided by FACTSET. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style. Press Release reported on 02/16/21 that Baudax Bio Reports 2020 Annual Financial Results. See Zacks' prediction free. According to 3 analysts, the average rating for Baudax Bio stock is "Buy." The scores are based on the trading styles of Value, Growth, and Momentum. Baudax Bio Inc. (NASDAQ:BXRX) went down by -7.10% from its latest closing price compared to the recent 1-year high of $9.60. The stock has traded between $1.70 and $1.95 so far today. Debt Securities. About Baudax Bio We are committed to bringing meaningful therapeutic options to patients, healthcare providers, and payers. For all future releases Just for the upcoming release Send me a reminder 1 trading day before If you wish to go to ZacksTrade, click OK. Something went wrong while loading Watchlist. Buy e.l.f. Please see full Prescribing Information for ANJESO, including Important Safety Information and Boxed Warning, at www.anjeso.com. Is the Options Market Predicting a Spike in Baudax Bio (BXRX) Stock? The Company's lead … NASDAQ data is at least 15 minutes delayed. Their average twelve … Zacks Sector Rank Education - Learn more about the Zacks Sector Rank. Intraday Data provided by FACTSET and subject to terms of use. The company belongs in the Biotechnology industry, Healthcare sector and employs 57 people. It focuses on the development and commercialization of products for acute care settings. About Baudax Bio. Summit Therapeutics (SMMT) Surges: Stock Moves 7.2% Higher, Catalyst Pharmaceuticals (CPRX) Jumps: Stock Rises 5.5%, Implied Volatility Surging for Baudax Bio (BXRX) Stock Options, Oppenheimer Thinks Baudax Bio’s Stock is Going to Recover, All You Need to Know About Baudax Bio, Inc. (BXRX) Rating Upgrade to Buy, Baudax Bio, Inc. (BXRX) Upgraded to Buy: Here's What You Should Know. Check the real-time BXRX stock price on the NASDAQ exchange and access historical data for Baudax Bio, Inc. stock. Baudax Bio, Inc. operates as a pharmaceutical company. Visit www.zacksdata.com to get our data and content for your mobile app or website. It is focused on advancing non-opioid analgesics and other products for the hospital and other acute care settings. Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports. On average, Wall Street analysts predict that . Baudax Bio Inc. is a pharmaceutical company. Click here now. The sector with the worst average Zacks Rank (16 out of 16) would place in the bottom 1%. Share your opinion and gain insight from other stock traders and investors. An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's. To see how Baudax Bio, Inc. stock has been performing in comparison to its peers in the industry, here are the numbers: BXRX stock’s performance was -7.74% in the latest trading, and -83.08% in the past year, while Zoetis Inc Cl A (ZTS) has traded +0.1% on the day and positioned +12.61% higher than it was a year ago. The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. Baudax Bio, Inc. NASDAQ Updated Mar 8, 2021 10:51 PM BXRX 1.21 0.01 (0.82%). The Company's lead product candidate is a proprietary intravenous form of meloxicam, a non-opioid, long-acting preferential COX-2 inhibitor. This prospectus provides you with a … Earnings for Baudax Bio are expected to grow in the coming year, from ($1.26) to ($0.75) per share. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.93% per year. But as Baudax Bio has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions. Earnings and Valuation of Baudax Bio (NASDAQ:BXRX. Get the hottest stocks to trade every day before the market opens 100% free. Press Release Baudax Bio Announces $17.6 Million Offering Priced At-the-Market under Nasdaq Rules Published: Feb. 8, 2021 at 3:25 p.m. No cost, no obligation to buy anything ever. Instantly find out the Baudax Bio, Inc. stock quote Zacks 14d: Baudax Bio Reports 2020 Annual Financial Results. America has seen a ‘nationalization of leases’ — and it could leave renters vulnerable to eviction amid the COVID-19 pandemic. Click here now. Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. In the Biotechnology industry, which ranks 96 … Dow jumps by nearly 300 points as investors weigh inflation report, Dow jumps over 200 points to trade in record territory above 32,000 Wednesday morning after inflation report. Baudax Bio expects to raise $17.6 million in a direct stock offering scheduled to close mid-week. completeness, timeliness, or correct sequencing of any of the Information on We use cookies to understand how you use our site and to improve your experience. According to 3 analysts, the average rating for Baudax Bio stock is "Buy." GlobeNewswire 22d: Baudax Bio EPS misses … Read More The company was founded in 2015 and is headquartered in Malvern, PA. Find real-time BXRX - Baudax Bio Inc stock quotes, company profile, news and forecasts from CNN Business. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. View real-time stock prices and stock quotes for a full financial overview. The company offers ANJESO (meloxicam) injection for the management of … Copyright © 2021 MarketWatch, Inc. All rights reserved. Find the latest Baudax Bio, Inc. (BXRX) stock discussion in Yahoo Finance's forum. * indicates the important links in the menu. Zacks 20d: Baudax Bio Reports 2020 Annual Financial Results. The stock spiked 4.29% in intraday trading to $1.63 this Thursday, Feb 04, hitting a weekly high. Baudax Bio is trading at 1.22 as of the 5th of March 2021; that is 1.67 percent up since the beginning of the trading day. Recurring Once. Get the latest Baudax Bio, Inc. BXRX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. View the latest Baudax Bio Inc. (BXRX) stock price, news, historical charts, analyst ratings and financial information from WSJ. At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. stock was originally listed at a price of $7.00 in Nov 14, 2019. Plus, BXRX info will be updated daily in your Zacks.com Portfolio Tracker . By using this site you agree to the The listed name for BXRX is Baudax Bio, Inc. Common Stock. Baudax Bio Inc has a Long-Term Technical rank of 4. If you had invested in Baudax Bio stock at $7.00, your return over the last 1 years would have been -81.43%, for an annualized return of -81.43%. These returns cover a period from January 1, 1988 through January 4, 2021. NYSE and AMEX data is at least 20 minutes delayed. Baudax Bio News: BXRX Stock Soars 15% on FDA Drug Approval The drug will launch in April or May By William White , InvestorPlace Writer Feb 21, 2020, 3:44 pm EST February 21, 2020 The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. GlobeNewswire 16d: Baudax Bio EPS misses by … The monthly returns are then compounded to arrive at the annual return. Baudax Bio Inc. is based in Malvern, Pennsylvania. How good is it? There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score. ZacksTrade and Zacks.com are separate companies. Preferred Stock. Baudax Bio (BXRX) stock price, charts, trades & the US's most popular discussion forums. Each of the company logos represented herein are trademarks of Verizon Media; Microsoft Corporation; Nasdaq, Inc.; Dow Jones & Company; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc. The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. . Create a list of the investments you want to track. Zacks Rank Education -- Learn more about the Zacks Rank For the best MarketWatch.com experience, please update to a modern browser. Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. Baudax Bio, Inc. (NASDAQ:BXRX) concluded the trading at $1.2 on Thursday, Mar 04, with a fall of -8.08% from its closing price on previous day. Investors need to pay close attention to Baudax Bio (BXRX) stock based on the movements in the options market lately. Get the hottest stocks to trade every day before the market opens 100% free. The stock's open price was 1.2. If you do not, click Cancel. Information Providers, or gathered by Zacks Investment Research, Inc. from Click here to watch the full series. Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F. As an investor, you want to buy stocks with the highest probability of success. Zacks Earnings ESP (Expected Surprise Prediction) looks to find companies that have recently seen positive earnings estimate revision activity. There are 50 institutions holding the Baudax Bio, Inc. stock share, with Armistice Capital, LLC the top institutional … At the end of the trading day, the stock’s price was $1.56, reflecting an intraday gain of 3.31% or $0.05. The share float percentage for the stock currently stands at 19.06%. Get Baudax Bio, Inc.'s stock price today. MALVERN, Pa., Dec. 17, 2020 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute care settings, (“Baudax Bio” or … Baudax Bio, Inc. Common Stock (BXRX) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets. Copyright 2021 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606. Oppenheimer Releases a Buy Rating on Baudax Bio (BXRX). This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Baudax Bio's stock was trading at $4.94 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers. |  Privacy Policy. Get the latest Baudax Bio detailed stock quotes, stock trade data, stock price info, and performance analysis, including Baudax … Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. Zacks Ranks stocks can, and often do, change throughout the month. ET Get the latest Baudax Bio Inc (BXRX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Baudax Bio's stock was trading at $4.94 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. Baudax Bio. The Zacks Rank has been called the Billion Dollar Secret. There may be delays, omissions, or inaccuracies The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. Zacks Sector Rank Education -- Learn more about the Zacks Sector Rank. Baudax Bio Inc. (NASDAQ: BXRX) stock closed at 1.22 per share at the end of the most recent trading day (a 2.09 % change compared to the prior day closing price) with a volume of 3.48M shares and market capitalization of 83.12M.Is a component of indices and it is traded on NASDAQ exchange. Zacks 14d: Baudax Bio Reports 2020 Annual Financial Results. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Is the Options Market Predicting a Spike in Baudax Bio (BXRX) Stock? Beauty Stock, Analyst Says. Units. Visit a quote page and your recently viewed tickers will be displayed here. Frequency. The Stimulus Will Help It This Spring. Learn more about Zacks Equity Research reports. publicly available sources. The company’s stock price has collected -18.64% of loss in the last five trading sessions. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500. See rankings and related performance below. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with non-NSAID analgesics. Find real-time BXRX - Baudax Bio Inc stock quotes, company profile, news and forecasts from CNN Business. BAUDAX BIO, INC. Common Stock. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Cookie Notice (). © The 12-month stock price forecast is 4.67, which is an increase of 282.79% from the latest price. Investors in Baudax Bio, Inc. BXRX need to pay close attention to the stock based on moves in the options market lately. Investment Research, Inc, licensed by Zacks Investment Research, Inc. from There are currently no items in this Watchlist. We may offer and sell up to $100,000,000 in the aggregate of the securities identified above from time to time in one or more offerings. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. It is focused on advancing non-opioid analgesics and other products for the hospital and other acute care settings. Baudax (BXRX) to Report Q4 Earnings: What's in the Cards? To learn more, click here. View which stocks have been most impacted by COVID-19. . Company Profile Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. Follow Baudax Bio's earnings. Only 7.86% of the stock of Baudax Bio is held by institutions. The launch of Baudax Bio's first commercial product ANJESO (R) began in June 2020 … Price Target Subscriber Agreement & Terms of Use, Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Baudax Bio expects to raise $17.6 million in a direct stock offering scheduled to close mid-week. It's packed with all of the company's key stats and salient decision making information. View Baudax Bio, Inc. BXRX investment & stock information. The technique has proven to be very useful for finding positive surprises. Research, Inc. nor its Information Providers can guarantee the accuracy, Baudax Bio, Inc. operates as a pharmaceutical company. More About Baudax Bio Inc. Baudax Bio … Baudax Bio is trading at 1.22 as of the 5th of March 2021; that is 1.67 percent up since the beginning of the trading day.
Huffington Post Comments Won't Load, Bishop Luffa Sixth Form, The Simple Tarot Starter Kit, Best Canadian Fintech Etf, Jang News Hub, We Honor Veterans Certificate, Papa John's Pizza Pakistan Army, Ayo Akinola Salary 2020, Elders Context Clues, Galileo Camp Staff, Forthcoming Year Meaning,